Peter J. Kahrilas, MD - Gastroenterology

Dr. Peter J. Kahrilas reviews medical content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. Dr. Kahrilas is a specialist in esophageal disease. He is involved in research on the mechanics of swallowing, the motor activity of the upper esophagus, and the pathophysiology of gastroesophageal reflux disease (GERD). He is a Professor in the Division of Gastroenterology in the Department of Medicine at Northwestern University's Medical School in Chicago, Illinois.

Education and Training

MD: University of Rochester School of Medicine and Dentistry, Rochester, NY, 1979

Residency in Internal Medicine: University Hospitals of Cleveland, Cleveland, OH, 1979-1982

Fellowship in Gastroenterology: Northwestern University, Chicago, IL, 1982-1984

Research Fellow in Gastrointestinal Motility: Medical College of Wisconsin, Milwaukee, WI, 1984-1986


American Board of Internal Medicine

Gastroenterology, American Board of Internal Medicine

Academic Appointments

Malcolm Robinson Visiting Professor, University of Oklahoma College of Medicine, Oklahoma City, OK, 2004

Wade Volwiler Visiting Professor, University of Washington School of Medicine, Seattle, WA, 2003

Northwestern University, Department of Medicine, Evanston, IL:

  • Gilbert Marquardt Professor of Medicine, Department of Medicine, 1999-present
  • Professor, Department of Communication Sciences and Disorders, 1995-present
  • Professor, Department of Medicine, 1995-1999
  • Associate Professor (with tenure), Department of Medicine, 1992-1995
  • Associate Professor, Department of Medicine, 1990-1992
  • Associate Professor, Department of Communication Sciences and Disorders, 1990-1992
  • Assistant Professor, Department of Communication Sciences and Disorders, 1988-1990
  • Assistant Professor, Department of Medicine, 1986-1990

Financial Disclosure

The final approval of Healthwise content is always made by a clinician with no financial conflicts.

Dr. Kahrilas is a member of the advisory board for Reckitt Benckiser. He also receives consulting honoraria from AstraZeneca, Pfizer, and Trimedyne Inc.

Current as of: June 27, 2014